Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Green

Showing results (41-50 of 433) with videos related to

Pageof 44
Sort By:
Hospital & Community Psychiatry|April 1, 1990
Clozapine: benefits and risksA I Green, C Salzman
RSC Medicinal Chemistry|November 15, 2021
Photochemical synthesis of an epigenetic focused tetrahydroquinoline libraryAdam I Green, George M Burslem
Journal of Dual Diagnosis|March 26, 2019
From the EditorsAlan I Green, E Sherwood Brown
Cell Chemical Biology|March 18, 2022
Degradation of NSD3: What to Myc of it all?Adam I Green, George M Burslem
Nature|September 12, 1970
Effect of gene dose on the immune response to a 2,4-dinitrophenyl glutamic acid lysine copolymerL Ellman, I Green, B Benacerraf
Current Psychiatry Reports|September 19, 2003
Pharmacotherapy for schizophrenia and co-occurring substance use disordersDouglas L Noordsy, Alan I Green
Clinical and Experimental Immunology|December 1, 1971
Strain difference in the immune response to hydralazine in inbred guinea-pigsL Ellman, J Inman, I Green
Journal of Dual Diagnosis|February 2, 2016
Trauma, Technology, and Routine Outcome MeasuresRobert E Drake, Alan I Green
Journal of Dual Diagnosis|March 9, 2016
Current Epidemiology and Emerging Interventions for People With Co-occurring Mental Illness and Substance Use DisordersAlan I Green, Robert E Drake
Journal of Dual Diagnosis|December 20, 2015
Progress in Dual Diagnosis Research: Innovation and Controlled TrialsRobert E Drake, Alan I Green
Pageof 44

Showing results (41-50 of 433) with videos related to

Sort By:
Pageof 44
Hospital & Community Psychiatry|April 1, 1990
Clozapine: benefits and risksA I Green, C Salzman
RSC Medicinal Chemistry|November 15, 2021
Photochemical synthesis of an epigenetic focused tetrahydroquinoline libraryAdam I Green, George M Burslem
Journal of Dual Diagnosis|March 26, 2019
From the EditorsAlan I Green, E Sherwood Brown
Cell Chemical Biology|March 18, 2022
Degradation of NSD3: What to Myc of it all?Adam I Green, George M Burslem
Nature|September 12, 1970
Effect of gene dose on the immune response to a 2,4-dinitrophenyl glutamic acid lysine copolymerL Ellman, I Green, B Benacerraf
Current Psychiatry Reports|September 19, 2003
Pharmacotherapy for schizophrenia and co-occurring substance use disordersDouglas L Noordsy, Alan I Green
Clinical and Experimental Immunology|December 1, 1971
Strain difference in the immune response to hydralazine in inbred guinea-pigsL Ellman, J Inman, I Green
Journal of Dual Diagnosis|February 2, 2016
Trauma, Technology, and Routine Outcome MeasuresRobert E Drake, Alan I Green
Journal of Dual Diagnosis|March 9, 2016
Current Epidemiology and Emerging Interventions for People With Co-occurring Mental Illness and Substance Use DisordersAlan I Green, Robert E Drake
Journal of Dual Diagnosis|December 20, 2015
Progress in Dual Diagnosis Research: Innovation and Controlled TrialsRobert E Drake, Alan I Green
Pageof 44